Chin Shih
Cardiovascular Disease · Monterey Park, CANPI 1013935154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $953 and has fallen 93.2% since, to $65 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in CA, where the typical reported total is $2,142.
Across 122 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$391
- Nestle Healthcare Nutrition Inc.$372
- Amgen$288
- Kowa Pharmaceuticals America, Inc.$264
- Amarin Pharma, Inc.$227
- Novartis$224
- plus $757 from 10 others
What the payments were for
- Food & beverage$2,522100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 19 | $391 |
| Nestle Healthcare Nutrition Inc. | 16 | $372 |
| Amgen | 14 | $288 |
| Kowa Pharmaceuticals America, Inc. | 17 | $264 |
| Amarin Pharma, Inc. | 13 | $227 |
| Novartis | 11 | $224 |
| Boehringer Ingelheim | 7 | $164 |
| E.r. Squibb & Sons, L.L.C. | 7 | $164 |
| AbbVie | 5 | $104 |
| Merck | 4 | $95 |
| Radius Health, Inc. | 2 | $68 |
| Pfizer | 2 | $50 |
| AstraZeneca | 2 | $46 |
| Biotronik Inc. | 1 | $35 |
| GSK | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$2,522 in reported general payments places this provider in the 50th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Monterey Park
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.